project type

Leukaemia

type

Advanced pre-clinical evaluation of sphingosine kinase 1-targeting agents as a therapy for acute myeloid leukaemia

SA
Read more

Developing a novel targeted therapy for treating chemotherapy-resistant leukaemia

NSW
Read more

Exploiting a new epigenetic regulatory mechanism for sustaining leukaemia-initiating activity

NSW
Read more

MARCH5 is a master regulator of BCL2 proteins and a potential anti-cancer drug target

VIC
Read more

Help us to put an end to cancer

Donate now